AstraZeneca Shareholders Revolt Again Over Executive Pay - theguardian.com -BoardProspects

AstraZeneca Shareholders Revolt Again Over Executive Pay

theguardian.com Apr 28 2017 BoardNews

AstraZeneca has suffered another shareholder revolt over executive pay, with two-fifths opposing a £13m package for its chief executive. Nearly 39% of investors voted against the pharmaceutical group’s 2016 remuneration report at its annual meeting in London, similar to the rebellion it faced three years ago . Support for the new pay policy was much stronger, with 96% of investors backing it...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Protesters target BP annual meeting also published in theguardian.com
- Germany's Corporate Governance Problem also categorized in BoardNews
- A corporation without a proper corporate structure also published in theguardian.com
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- BT investors vent anger at bonus also published in theguardian.com
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned
Authors
- Julia Kollewe